Quotes

Back To Menu

Nippon India Pharma Fund (IDCW) Equity - Pharma
INVEST

Plan: OPEN | Option: Dividend | Sailesh Raj Bhan

25 Oct 24 | 12:00 AM

128.80 -0.43 (-0.33%)

  • Outperforms

    48.76%

    Return (1Y)

    beaten BSE Healthcare TRI by 0.45%

  • Less Volatile

    0.75%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.21%

  • Inconsistent

    2/6

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Nippon India Pharma Fund (IDCW), has underperformed by 0.45% (CAGR difference)

48.76%

Outperforms

This is Alpha

Performance Chart for Rs

Invested in

23 Nov 2023

Risk

In last 1 year , the volatility of Nippon India Pharma Fund (IDCW) is Lower than by -0.21%

0.75%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 2 out of Last 6 Months, i.e 33.33% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition